Download a PDF of Chapter 5 - Ethical issues in treatment and clinical practice (1.4MB)
The introduction of pharmacogenetics will mean that many more patients are exposed to genetic testing than before. Currently, patients tend only to encounter genetics in the context of serious diseases such as cystic fibrosis and Huntington’s disease.